Targeted Therapies and Innovations in Bone Cancer Management
*Corresponding Author:Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Citation: Jason M (2024) Targeted Therapies and Innovations in Bone Cancer Management. J Orthop Oncol 10: 289DOI: 10.4172/2472-016X.1000289
Copyright: 漏 2024 Jason M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Abstract
Bone cancer encompasses a range of malignancies, including primary tumors such as osteosarcoma, Ewing sarcoma, and chondrosarcoma, as well as secondary metastatic lesions. Traditional management approaches— surgery, chemotherapy, and radiotherapy-have improved survival rates but are associated with significant morbidity. Recent advances in targeted therapies, including immunotherapies, small-molecule inhibitors, and gene-editing technologies, have transformed the treatment landscape. This article reviews the molecular basis of bone cancer, emerging therapeutic targets, innovations in drug delivery, and ongoing challenges in clinical application. The role of a multidisciplinary approach in optimizing outcomes is also emphasized.
